| # | Company | Location | Employees | Total Funding | Last Round | Last Funded |
|---|---|---|---|---|---|---|
| 1 |
Parabilis Medicines
Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specialize…
|
Cambridge | 101 - 250 | $835.3M | Series F | 2026-01-08 |
| 2 |
Alumis
Alumis is a precision medicine company focused on the discovery, development and…
|
San Francisco | 101 - 250 | $917.2M | Post Ipo Equity | 2026-01-07 |
| 3 |
Tempus
Tempus develops AI-enabled precision medicine technology that supports clinical …
|
Chicago | 1K - 5K | $2.3B | Post Ipo Debt | 2025-06-30 |
| 4 |
Pfizer
Pfizer is a biopharmaceutical company that discovers, develops, and delivers med…
|
New York | c 10001 max | $38.0B | Post Ipo Debt | 2025-11-21 |
| 5 |
HealthEx
HealthEx builds a patient-centric future for health data collaboration to unlock…
|
San Francisco | 11 - 50 | $14.0M | Series A | 2024-10-21 |
| 6 |
Novartis
Novartis is a pharmaceutical company that researches and develops medicines for …
|
Basel | c 10001 max | $2.5B | Post Ipo Debt | 2024-06-19 |
| 7 |
Roche
Roche is a pharmaceutical and diagnostics company that offers medicines and diag…
|
Basel | c 10001 max | $7.8B | Post Ipo Equity | 2021-08-04 |
| 8 |
Thermo Fisher Scientific
Thermo Fisher Scientific is a biotechnology and laboratory equipment company tha…
|
Waltham | c 10001 max | $19.8B | Post Ipo Debt | 2026-02-09 |
| 9 |
Brainomix
Brainomix specializes in the creation of AI-powered imaging biomarkers that enab…
|
Oxford | 51 - 100 | $60.2M | Series C | 2026-02-24 |
| 10 |
Genomate Health
Genomate Health is a digital health company that develops computational (AI) sol…
|
Cambridge | 11 - 50 | $10.0M | Seed | 2025-04-01 |
| 11 |
Daisy Genomics
Daisy Genomics is an medtech focused on developing its proprietary long-read DNA…
|
Carlsbad | 1 - 10 | $8.4M | Seed | 2025-12-17 |
| 12 |
Waiv
Owkin is an AI precision medicine company with a vision to find the right drug f…
|
New York | 251 - 500 | $337.1M | Series Unknown | 2026-03-12 |
| 13 |
Amissa Health
Amissa powers evidence-based perimenopause care with AI-enabled clinical decisio…
|
Charlotte | 1 - 10 | $3.8M | Grant | 2025-03-17 |
| 14 |
Bristol-Myers Squibb
Bristol-Myers Squibb engages in the discovery, development, licensing, manufactu…
|
New York | c 10001 max | $29.3B | Post Ipo Debt | 2025-11-05 |
| 15 |
Alto Neuroscience
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates pre…
|
Los Altos | 51 - 100 | $421.0M | Post Ipo Equity | 2026-03-16 |
| 16 |
PGxAI
Precision medicine platform powered by GenAI and real world evidence.
|
Palo Alto | 11 - 50 | $2.0M | Seed | 2024-12-24 |
| 17 |
QurAlis
QurAlis is a biotechnology company that creates precision medicine solutions to …
|
Cambridge | 51 - 100 | $135.5M | Series B | 2023-03-09 |
| 18 |
CurifyLabs
CurifyLabs is transforming how personalized medicines are made
|
Helsinki | 11 - 50 | $16.0M | Seed | 2025-05-27 |
| 19 |
OutSee
OutSee creates cutting-edge computational methods for genomics for the developme…
|
Cambridge | 1 - 10 | $3.4M | Seed | 2025-06-24 |
| 20 |
Artera
Artera develops multimodal artificial intelligence-based predictive and prognost…
|
Los Altos | 101 - 250 | $110.0M | Series Unknown | 2024-02-01 |
| 21 |
Praxis Precision Medicines
Praxis develops therapies for CNS disorders by leveraging genetic insights into …
|
Cambridge | 101 - 250 | $1.7B | Post Ipo Equity | 2026-01-06 |
| 22 |
Nido Biosciences
Nido Biosciences is a clinical-stage company that develops precision medicines f…
|
Watertown | 11 - 50 | $109.0M | Series B | 2023-05-15 |
| 23 |
Treeline Biosciences
Treeline Biosciences is a biotech company building transformative precision medi…
|
Watertown | 101 - 250 | $1.1B | Series A | 2025-09-03 |
| 24 |
OM1
OM1 is a healthcare technology company that leverages real-world clinical data f…
|
Boston | 101 - 250 | $171.0M | Series D | 2021-07-16 |
| 25 |
Elucid
Elucid enables precision medicine for cardiovascular disease by applying A.I to …
|
Boston | 101 - 250 | $166.2M | Series D | 2025-10-22 |
| 26 |
Future Cardia
Future Cardia is a healthcare company that is developing a compact cardiac devic…
|
Houston | 1 - 10 | $10.8M | Equity Crowdfunding | 2024-06-03 |
| 27 |
Cofactor Genomics
Cofactor Genomics builds multidimensional models of disease to deliver true prec…
|
San Francisco | 11 - 50 | $29.0M | Series Unknown | 2025-12-15 |
| 28 |
Qiagen
QIAGEN provides technologies and products for preanalytical sample preparation a…
|
Venlo | 5K - 10K | $754.0M | Post Ipo Debt | 2025-08-28 |
| 29 |
Epic Sciences
Epic Sciences is a diagnostics company improving cancer management by providing …
|
La Jolla | 101 - 250 | $219.5M | Series G | 2023-04-14 |
| 30 |
Genialis
Genialis is a computational precision medicines company that develops a clinical…
|
Boston | 11 - 50 | $15.5M | Series A | 2023-03-29 |
| 31 |
Revero
Digital health clinic, treating chronic disease with personalized medical care, …
|
San Francisco | 1 - 10 | $6.3M | Seed | 2022-11-03 |
| 32 |
Octave
Octave is a precision care company that provides diagnostic tools and care solut…
|
Menlo Park | 101 - 250 | $142.1M | Grant | 2025-10-06 |
| 33 |
BC Platforms
BC Platforms is a data and technology company providing tools to advance the dev…
|
Z├╝rich | 101 - 250 | $45.3M | Private Equity | 2022-11-08 |
| 34 |
Network Bio
Network Bio's biomedical data for AI-enabled precision medicine
|
New York | 11 - 50 | $19.5M | Seed | 2025-02-27 |
| 35 |
Clarity Pharmaceuticals
Clarity Pharmaceuticals is a personalized medicine company focused on the treatm…
|
Sydney | 11 - 50 | $142.1M | Post Ipo Equity | 2025-07-28 |
| 36 |
Owlstone Medical
Owlstone Medical develops healthcare non-invasive breath-based diagnostic tools …
|
Cambridge | 101 - 250 | $217.8M | Grant | 2025-10-06 |
| 37 |
Karius
Karius delivers genomic insights into infectious diseases, helping clinicians ma…
|
Redwood City | 101 - 250 | $354.0M | Series C | 2024-05-02 |
| 38 |
Rapport Therapeutics
Rapport Therapeutics is a clinical-stage biotechnology company that discovers an…
|
Boston | 51 - 100 | $500.0M | Post Ipo Equity | 2025-09-09 |
| 39 |
Frontier Medicines
Frontier Medicines is a biopharmaceutical company that develops a chemoproteomic…
|
San Francisco | 101 - 250 | $255.5M | Series C | 2024-06-25 |
| 40 |
Raidium
Radiology augmented GPT to tackle the complexity of precision medicine
|
Paris | 11 - 50 | $19.6M | Seed | 2024-11-28 |
| 41 |
Thryv Therapeutics
Thryv Therapeutics is a precision medicine approach to treat patients with Long …
|
Laval | 11 - 50 | $40.4M | Series Unknown | 2025-09-17 |
| 42 |
Polaris Quantum Biotech
Polaris Quantum Biotech revolutionizes drug design by joining quantum computing …
|
Durham | 1 - 10 | $2.1M | Seed | 2024-12-30 |
| 43 |
BioMap
BioMap is a pioneer in life science AI Foundation Models
|
Palo Alto | 101 - 250 | $100.0M | Series Unknown | 2024-06-19 |
| 44 |
OnKure Therapeutics
OnKure is a clinical-stage biopharma company developing precision medicines targ…
|
Boulder | 11 - 50 | $336.5M | Post Ipo Equity | 2026-03-27 |
| 45 |
Grupo Oncoclinicas
Grupo Oncoclinicas offers health care services such as OC precision medicine, ra…
|
Belo Horizonte | 1K - 5K | $194.4M | Post Ipo Secondary | 2025-03-24 |
| 46 |
Precision Medicine Group
Precision Medicine Group specializes in medicine development and commercializati…
|
Bethesda | 1K - 5K | $310.2M | Series Unknown | 2021-03-25 |
| 47 |
RootPath
RootPath is a biotechnology company developing a powerful personalized T cell th…
|
Cambridge | 11 - 50 | $69.4M | Series Unknown | 2025-04-24 |
| 48 |
Myriad Genetics
Myriad Genetics discovers, develops, and commercializing novel therapies for the…
|
Salt Lake City | 1K - 5K | $215.0M | Post Ipo Debt | 2025-07-31 |
| 49 |
SEngine Precision Medicine
SEngine Precision Medicine uses algorithms and 3D organoid technology to develop…
|
Seattle | 11 - 50 | $21.2M | Series A | 2022-07-28 |
| 50 |
Imaginostics
Imaginostics is creating the next generation of precision medicine diagnostic an…
|
Orlando | 1 - 10 | $8.4M | Seed | 2024-06-01 |